BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1720126)

  • 1. Clonal composition of pituitary adenomas in patients with Cushing's disease: determination by X-chromosome inactivation analysis.
    Schulte HM; Oldfield EH; Allolio B; Katz DA; Berkman RA; Ali IU
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1302-8. PubMed ID: 1720126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal origin of pituitary adenomas.
    Herman V; Fagin J; Gonsky R; Kovacs K; Melmed S
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1427-33. PubMed ID: 1977759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinically nonfunctioning pituitary tumors are monoclonal in origin.
    Alexander JM; Biller BM; Bikkal H; Zervas NT; Arnold A; Klibanski A
    J Clin Invest; 1990 Jul; 86(1):336-40. PubMed ID: 1973174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonality of corticotroph macroadenomas in Cushing's disease.
    Gicquel C; Le Bouc Y; Luton JP; Girard F; Bertagna X
    J Clin Endocrinol Metab; 1992 Aug; 75(2):472-5. PubMed ID: 1322426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal origins of adrenocorticotropin-secreting pituitary tissue in Cushing's disease.
    Biller BM; Alexander JM; Zervas NT; Hedley-Whyte ET; Arnold A; Klibanski A
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1303-9. PubMed ID: 1358909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal composition of human adrenocortical neoplasms.
    Beuschlein F; Reincke M; Karl M; Travis WD; Jaursch-Hancke C; Abdelhamid S; Chrousos GP; Allolio B
    Cancer Res; 1994 Sep; 54(18):4927-32. PubMed ID: 7915195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal analysis of human adrenocortical carcinomas and secreting adenomas.
    Gicquel C; Leblond-Francillard M; Bertagna X; Louvel A; Chapuis Y; Luton JP; Girard F; Le Bouc Y
    Clin Endocrinol (Oxf); 1994 Apr; 40(4):465-77. PubMed ID: 7910530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
    Katznelson L; Bogan JS; Trob JR; Schoenfeld DA; Hedley-Whyte ET; Hsu DW; Zervas NT; Swearingen B; Sleeper M; Klibanski A
    J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal analysis using recombinant DNA probes from the X-chromosome.
    Vogelstein B; Fearon ER; Hamilton SR; Preisinger AC; Willard HF; Michelson AM; Riggs AD; Orkin SH
    Cancer Res; 1987 Sep; 47(18):4806-13. PubMed ID: 2887283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal composition of benign and malignant human thyroid tumors.
    Namba H; Matsuo K; Fagin JA
    J Clin Invest; 1990 Jul; 86(1):120-5. PubMed ID: 1973172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple cellular forms of corticotrophs in surgically removed pituitary adenomas and periadenomatous tissue in Cushing's disease.
    Martin R; Cetin Y; Fehm HL; Fahlbusch R; Voigt KH
    Am J Pathol; 1982 Mar; 106(3):332-41. PubMed ID: 6278938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary pathology in Cushing's disease.
    Saeger W; Geisler F; Lüdecke DK
    Pathol Res Pract; 1988 Sep; 183(5):592-5. PubMed ID: 3237549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute myeloid leukemia: analysis of ras gene mutations and clonality defined by polymorphic X-linked loci.
    Bartram CR; Ludwig WD; Hiddemann W; Lyons J; Buschle M; Ritter J; Harbott J; Fröhlich A; Janssen JW
    Leukemia; 1989 Apr; 3(4):247-56. PubMed ID: 2564452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of pro-opiomelanocortin mRNA in pituitary adenomas and para-adenomatous gland in Cushing's disease and Nelson's syndrome.
    Fehn M; Farquharson MA; Sautner D; Saeger W; Lüdecke DK; McNicol AM
    J Pathol; 1993 Mar; 169(3):335-9. PubMed ID: 8492226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular pathology shows p16 methylation in nonadenomatous pituitaries from patients with Cushing's disease.
    Simpson DJ; McNicol AM; Murray DC; Bahar A; Turner HE; Wass JA; Esiri MM; Clayton RN; Farrell WE
    Clin Cancer Res; 2004 Mar; 10(5):1780-8. PubMed ID: 15014032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperprolactinemia in Cushing's disease and Nelson's syndrome.
    Yamaji T; Ishibashi M; Teramoto A; Fukushima T
    J Clin Endocrinol Metab; 1984 May; 58(5):790-5. PubMed ID: 6323516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal composition of glioblastoma multiforme.
    Berkman RA; Clark WC; Saxena A; Robertson JT; Oldfield EH; Ali IU
    J Neurosurg; 1992 Sep; 77(3):432-7. PubMed ID: 1324297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal origin of pituitary adenomas.
    Jacoby LB; Hedley-Whyte ET; Pulaski K; Seizinger BR; Martuza RL
    J Neurosurg; 1990 Nov; 73(5):731-5. PubMed ID: 2213163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal analysis of chronic myeloproliferative disorders using X-linked DNA polymorphisms.
    Anger B; Janssen JW; Schrezenmeier H; Hehlmann R; Heimpel H; Bartram CR
    Leukemia; 1990 Apr; 4(4):258-61. PubMed ID: 1973205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human corticotroph cell adenomas.
    Robert F; Hardy J
    Semin Diagn Pathol; 1986 Feb; 3(1):34-41. PubMed ID: 3039631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.